AACR Virtual Annual Meeting I: Innovative Immunotherapeutic Strategies
Clinical trials were a major focus of the AACR Virtual Annual Meeting I, spanning nine plenary sessions over the two-day...
Progress Against Cancer
Clinical trials were a major focus of the AACR Virtual Annual Meeting I, spanning nine plenary sessions over the two-day...
A study indicates that children with cancer are not at increased risks of severe cases of COVID-19.
In the United States, nearly 24,000 people are estimated to receive a brain or nervous system cancer diagnosis in 2020....
“The field of cell therapy is one of the most exciting fields in translational medicine,” began Katayoun Rezvani, MD, PhD,...
Bladder cancer is a common malignancy originating in the bladder, a hollow organ located in the abdomen that stores urine. It is the sixth most prevalent cancer in the United...
A study finds that the rate of death from opioids was 10 times lower in cancer patients than in...
Over the past decade, immune checkpoint inhibitors have transformed cancer care for a variety of tumor types. This form of immunotherapy can lead to long-lasting...
Researchers present new data on cancer biology, treatment, screening and risk reduction at the AACR Virtual Annual Meeting I.
At the AACR Virtual Annual Meeting I, researchers presented data on blood tests that aim to supplement current cancer...
Early detection of most cancers is an elusive and daunting task; nevertheless, it has remained a top priority for...